Global Nuclear Medicine Imaging Agents Supply, Demand and Key Producers, 2023-2029
The global Nuclear Medicine Imaging Agents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Nuclear Medicine Imaging Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine Imaging Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine Imaging Agents that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine Imaging Agents total production and demand, 2018-2029, (K Units)
Global Nuclear Medicine Imaging Agents total production value, 2018-2029, (USD Million)
Global Nuclear Medicine Imaging Agents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nuclear Medicine Imaging Agents consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nuclear Medicine Imaging Agents domestic production, consumption, key domestic manufacturers and share
Global Nuclear Medicine Imaging Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nuclear Medicine Imaging Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nuclear Medicine Imaging Agents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Nuclear Medicine Imaging Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health and Blue Earth Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Medicine Imaging Agents market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nuclear Medicine Imaging Agents Market, By Region:
1. How big is the global Nuclear Medicine Imaging Agents market?
2. What is the demand of the global Nuclear Medicine Imaging Agents market?
3. What is the year over year growth of the global Nuclear Medicine Imaging Agents market?
4. What is the production and production value of the global Nuclear Medicine Imaging Agents market?
5. Who are the key producers in the global Nuclear Medicine Imaging Agents market?
6. What are the growth factors driving the market demand?
This report studies the global Nuclear Medicine Imaging Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine Imaging Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine Imaging Agents that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine Imaging Agents total production and demand, 2018-2029, (K Units)
Global Nuclear Medicine Imaging Agents total production value, 2018-2029, (USD Million)
Global Nuclear Medicine Imaging Agents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nuclear Medicine Imaging Agents consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nuclear Medicine Imaging Agents domestic production, consumption, key domestic manufacturers and share
Global Nuclear Medicine Imaging Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nuclear Medicine Imaging Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nuclear Medicine Imaging Agents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Nuclear Medicine Imaging Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health and Blue Earth Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Medicine Imaging Agents market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nuclear Medicine Imaging Agents Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Fluorine 18 Labeling
- Carbon 11 Labeling
- Nitrogen 13 Labeling
- Oxygen 15 Labeling
- Technetium 99 Labeling
- Others
- Early Diagnosis
- Clinical Stage
- Treatment Evaluation
- GE HealthCare
- Bracco Diagnostic
- Guerbet
- Mallinckrodt
- Lantheus
- Yantai Dongcheng
- Foshan Rui Diao Pharmaceutical
- Cardinal Health
- Blue Earth Diagnostics
- Bayer AG
- Abx Advanced Biochemical
- Eli Lilly and Company
- Jubilant Pharma Limited
- Navidea
1. How big is the global Nuclear Medicine Imaging Agents market?
2. What is the demand of the global Nuclear Medicine Imaging Agents market?
3. What is the year over year growth of the global Nuclear Medicine Imaging Agents market?
4. What is the production and production value of the global Nuclear Medicine Imaging Agents market?
5. Who are the key producers in the global Nuclear Medicine Imaging Agents market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nuclear Medicine Imaging Agents Introduction
1.2 World Nuclear Medicine Imaging Agents Supply & Forecast
1.2.1 World Nuclear Medicine Imaging Agents Production Value (2018 & 2022 & 2029)
1.2.2 World Nuclear Medicine Imaging Agents Production (2018-2029)
1.2.3 World Nuclear Medicine Imaging Agents Pricing Trends (2018-2029)
1.3 World Nuclear Medicine Imaging Agents Production by Region (Based on Production Site)
1.3.1 World Nuclear Medicine Imaging Agents Production Value by Region (2018-2029)
1.3.2 World Nuclear Medicine Imaging Agents Production by Region (2018-2029)
1.3.3 World Nuclear Medicine Imaging Agents Average Price by Region (2018-2029)
1.3.4 North America Nuclear Medicine Imaging Agents Production (2018-2029)
1.3.5 Europe Nuclear Medicine Imaging Agents Production (2018-2029)
1.3.6 China Nuclear Medicine Imaging Agents Production (2018-2029)
1.3.7 Japan Nuclear Medicine Imaging Agents Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Medicine Imaging Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nuclear Medicine Imaging Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nuclear Medicine Imaging Agents Demand (2018-2029)
2.2 World Nuclear Medicine Imaging Agents Consumption by Region
2.2.1 World Nuclear Medicine Imaging Agents Consumption by Region (2018-2023)
2.2.2 World Nuclear Medicine Imaging Agents Consumption Forecast by Region (2024-2029)
2.3 United States Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.4 China Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.5 Europe Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.6 Japan Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.7 South Korea Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.8 ASEAN Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.9 India Nuclear Medicine Imaging Agents Consumption (2018-2029)
3 WORLD NUCLEAR MEDICINE IMAGING AGENTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nuclear Medicine Imaging Agents Production Value by Manufacturer (2018-2023)
3.2 World Nuclear Medicine Imaging Agents Production by Manufacturer (2018-2023)
3.3 World Nuclear Medicine Imaging Agents Average Price by Manufacturer (2018-2023)
3.4 Nuclear Medicine Imaging Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nuclear Medicine Imaging Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nuclear Medicine Imaging Agents in 2022
3.5.3 Global Concentration Ratios (CR8) for Nuclear Medicine Imaging Agents in 2022
3.6 Nuclear Medicine Imaging Agents Market: Overall Company Footprint Analysis
3.6.1 Nuclear Medicine Imaging Agents Market: Region Footprint
3.6.2 Nuclear Medicine Imaging Agents Market: Company Product Type Footprint
3.6.3 Nuclear Medicine Imaging Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nuclear Medicine Imaging Agents Production Value Comparison
4.1.1 United States VS China: Nuclear Medicine Imaging Agents Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nuclear Medicine Imaging Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nuclear Medicine Imaging Agents Production Comparison
4.2.1 United States VS China: Nuclear Medicine Imaging Agents Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nuclear Medicine Imaging Agents Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nuclear Medicine Imaging Agents Consumption Comparison
4.3.1 United States VS China: Nuclear Medicine Imaging Agents Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nuclear Medicine Imaging Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nuclear Medicine Imaging Agents Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nuclear Medicine Imaging Agents Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023)
4.5 China Based Nuclear Medicine Imaging Agents Manufacturers and Market Share
4.5.1 China Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nuclear Medicine Imaging Agents Production Value (2018-2023)
4.5.3 China Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023)
4.6 Rest of World Based Nuclear Medicine Imaging Agents Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Medicine Imaging Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Fluorine 18 Labeling
5.2.2 Carbon 11 Labeling
5.2.3 Nitrogen 13 Labeling
5.2.4 Oxygen 15 Labeling
5.2.5 Technetium 99 Labeling
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Nuclear Medicine Imaging Agents Production by Type (2018-2029)
5.3.2 World Nuclear Medicine Imaging Agents Production Value by Type (2018-2029)
5.3.3 World Nuclear Medicine Imaging Agents Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nuclear Medicine Imaging Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Early Diagnosis
6.2.2 Clinical Stage
6.2.3 Treatment Evaluation
6.3 Market Segment by Application
6.3.1 World Nuclear Medicine Imaging Agents Production by Application (2018-2029)
6.3.2 World Nuclear Medicine Imaging Agents Production Value by Application (2018-2029)
6.3.3 World Nuclear Medicine Imaging Agents Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 GE HealthCare
7.1.1 GE HealthCare Details
7.1.2 GE HealthCare Major Business
7.1.3 GE HealthCare Nuclear Medicine Imaging Agents Product and Services
7.1.4 GE HealthCare Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 GE HealthCare Recent Developments/Updates
7.1.6 GE HealthCare Competitive Strengths & Weaknesses
7.2 Bracco Diagnostic
7.2.1 Bracco Diagnostic Details
7.2.2 Bracco Diagnostic Major Business
7.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Product and Services
7.2.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bracco Diagnostic Recent Developments/Updates
7.2.6 Bracco Diagnostic Competitive Strengths & Weaknesses
7.3 Guerbet
7.3.1 Guerbet Details
7.3.2 Guerbet Major Business
7.3.3 Guerbet Nuclear Medicine Imaging Agents Product and Services
7.3.4 Guerbet Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Guerbet Recent Developments/Updates
7.3.6 Guerbet Competitive Strengths & Weaknesses
7.4 Mallinckrodt
7.4.1 Mallinckrodt Details
7.4.2 Mallinckrodt Major Business
7.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Product and Services
7.4.4 Mallinckrodt Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Mallinckrodt Recent Developments/Updates
7.4.6 Mallinckrodt Competitive Strengths & Weaknesses
7.5 Lantheus
7.5.1 Lantheus Details
7.5.2 Lantheus Major Business
7.5.3 Lantheus Nuclear Medicine Imaging Agents Product and Services
7.5.4 Lantheus Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lantheus Recent Developments/Updates
7.5.6 Lantheus Competitive Strengths & Weaknesses
7.6 Yantai Dongcheng
7.6.1 Yantai Dongcheng Details
7.6.2 Yantai Dongcheng Major Business
7.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Product and Services
7.6.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Yantai Dongcheng Recent Developments/Updates
7.6.6 Yantai Dongcheng Competitive Strengths & Weaknesses
7.7 Foshan Rui Diao Pharmaceutical
7.7.1 Foshan Rui Diao Pharmaceutical Details
7.7.2 Foshan Rui Diao Pharmaceutical Major Business
7.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product and Services
7.7.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Foshan Rui Diao Pharmaceutical Recent Developments/Updates
7.7.6 Foshan Rui Diao Pharmaceutical Competitive Strengths & Weaknesses
7.8 Cardinal Health
7.8.1 Cardinal Health Details
7.8.2 Cardinal Health Major Business
7.8.3 Cardinal Health Nuclear Medicine Imaging Agents Product and Services
7.8.4 Cardinal Health Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Cardinal Health Recent Developments/Updates
7.8.6 Cardinal Health Competitive Strengths & Weaknesses
7.9 Blue Earth Diagnostics
7.9.1 Blue Earth Diagnostics Details
7.9.2 Blue Earth Diagnostics Major Business
7.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product and Services
7.9.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Blue Earth Diagnostics Recent Developments/Updates
7.9.6 Blue Earth Diagnostics Competitive Strengths & Weaknesses
7.10 Bayer AG
7.10.1 Bayer AG Details
7.10.2 Bayer AG Major Business
7.10.3 Bayer AG Nuclear Medicine Imaging Agents Product and Services
7.10.4 Bayer AG Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bayer AG Recent Developments/Updates
7.10.6 Bayer AG Competitive Strengths & Weaknesses
7.11 Abx Advanced Biochemical
7.11.1 Abx Advanced Biochemical Details
7.11.2 Abx Advanced Biochemical Major Business
7.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product and Services
7.11.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Abx Advanced Biochemical Recent Developments/Updates
7.11.6 Abx Advanced Biochemical Competitive Strengths & Weaknesses
7.12 Eli Lilly and Company
7.12.1 Eli Lilly and Company Details
7.12.2 Eli Lilly and Company Major Business
7.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Product and Services
7.12.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Eli Lilly and Company Recent Developments/Updates
7.12.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.13 Jubilant Pharma Limited
7.13.1 Jubilant Pharma Limited Details
7.13.2 Jubilant Pharma Limited Major Business
7.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product and Services
7.13.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Jubilant Pharma Limited Recent Developments/Updates
7.13.6 Jubilant Pharma Limited Competitive Strengths & Weaknesses
7.14 Navidea
7.14.1 Navidea Details
7.14.2 Navidea Major Business
7.14.3 Navidea Nuclear Medicine Imaging Agents Product and Services
7.14.4 Navidea Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Navidea Recent Developments/Updates
7.14.6 Navidea Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nuclear Medicine Imaging Agents Industry Chain
8.2 Nuclear Medicine Imaging Agents Upstream Analysis
8.2.1 Nuclear Medicine Imaging Agents Core Raw Materials
8.2.2 Main Manufacturers of Nuclear Medicine Imaging Agents Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nuclear Medicine Imaging Agents Production Mode
8.6 Nuclear Medicine Imaging Agents Procurement Model
8.7 Nuclear Medicine Imaging Agents Industry Sales Model and Sales Channels
8.7.1 Nuclear Medicine Imaging Agents Sales Model
8.7.2 Nuclear Medicine Imaging Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Nuclear Medicine Imaging Agents Introduction
1.2 World Nuclear Medicine Imaging Agents Supply & Forecast
1.2.1 World Nuclear Medicine Imaging Agents Production Value (2018 & 2022 & 2029)
1.2.2 World Nuclear Medicine Imaging Agents Production (2018-2029)
1.2.3 World Nuclear Medicine Imaging Agents Pricing Trends (2018-2029)
1.3 World Nuclear Medicine Imaging Agents Production by Region (Based on Production Site)
1.3.1 World Nuclear Medicine Imaging Agents Production Value by Region (2018-2029)
1.3.2 World Nuclear Medicine Imaging Agents Production by Region (2018-2029)
1.3.3 World Nuclear Medicine Imaging Agents Average Price by Region (2018-2029)
1.3.4 North America Nuclear Medicine Imaging Agents Production (2018-2029)
1.3.5 Europe Nuclear Medicine Imaging Agents Production (2018-2029)
1.3.6 China Nuclear Medicine Imaging Agents Production (2018-2029)
1.3.7 Japan Nuclear Medicine Imaging Agents Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Medicine Imaging Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nuclear Medicine Imaging Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nuclear Medicine Imaging Agents Demand (2018-2029)
2.2 World Nuclear Medicine Imaging Agents Consumption by Region
2.2.1 World Nuclear Medicine Imaging Agents Consumption by Region (2018-2023)
2.2.2 World Nuclear Medicine Imaging Agents Consumption Forecast by Region (2024-2029)
2.3 United States Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.4 China Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.5 Europe Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.6 Japan Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.7 South Korea Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.8 ASEAN Nuclear Medicine Imaging Agents Consumption (2018-2029)
2.9 India Nuclear Medicine Imaging Agents Consumption (2018-2029)
3 WORLD NUCLEAR MEDICINE IMAGING AGENTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nuclear Medicine Imaging Agents Production Value by Manufacturer (2018-2023)
3.2 World Nuclear Medicine Imaging Agents Production by Manufacturer (2018-2023)
3.3 World Nuclear Medicine Imaging Agents Average Price by Manufacturer (2018-2023)
3.4 Nuclear Medicine Imaging Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nuclear Medicine Imaging Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nuclear Medicine Imaging Agents in 2022
3.5.3 Global Concentration Ratios (CR8) for Nuclear Medicine Imaging Agents in 2022
3.6 Nuclear Medicine Imaging Agents Market: Overall Company Footprint Analysis
3.6.1 Nuclear Medicine Imaging Agents Market: Region Footprint
3.6.2 Nuclear Medicine Imaging Agents Market: Company Product Type Footprint
3.6.3 Nuclear Medicine Imaging Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nuclear Medicine Imaging Agents Production Value Comparison
4.1.1 United States VS China: Nuclear Medicine Imaging Agents Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nuclear Medicine Imaging Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nuclear Medicine Imaging Agents Production Comparison
4.2.1 United States VS China: Nuclear Medicine Imaging Agents Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nuclear Medicine Imaging Agents Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nuclear Medicine Imaging Agents Consumption Comparison
4.3.1 United States VS China: Nuclear Medicine Imaging Agents Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nuclear Medicine Imaging Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nuclear Medicine Imaging Agents Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nuclear Medicine Imaging Agents Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023)
4.5 China Based Nuclear Medicine Imaging Agents Manufacturers and Market Share
4.5.1 China Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nuclear Medicine Imaging Agents Production Value (2018-2023)
4.5.3 China Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023)
4.6 Rest of World Based Nuclear Medicine Imaging Agents Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Medicine Imaging Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Fluorine 18 Labeling
5.2.2 Carbon 11 Labeling
5.2.3 Nitrogen 13 Labeling
5.2.4 Oxygen 15 Labeling
5.2.5 Technetium 99 Labeling
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Nuclear Medicine Imaging Agents Production by Type (2018-2029)
5.3.2 World Nuclear Medicine Imaging Agents Production Value by Type (2018-2029)
5.3.3 World Nuclear Medicine Imaging Agents Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nuclear Medicine Imaging Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Early Diagnosis
6.2.2 Clinical Stage
6.2.3 Treatment Evaluation
6.3 Market Segment by Application
6.3.1 World Nuclear Medicine Imaging Agents Production by Application (2018-2029)
6.3.2 World Nuclear Medicine Imaging Agents Production Value by Application (2018-2029)
6.3.3 World Nuclear Medicine Imaging Agents Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 GE HealthCare
7.1.1 GE HealthCare Details
7.1.2 GE HealthCare Major Business
7.1.3 GE HealthCare Nuclear Medicine Imaging Agents Product and Services
7.1.4 GE HealthCare Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 GE HealthCare Recent Developments/Updates
7.1.6 GE HealthCare Competitive Strengths & Weaknesses
7.2 Bracco Diagnostic
7.2.1 Bracco Diagnostic Details
7.2.2 Bracco Diagnostic Major Business
7.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Product and Services
7.2.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bracco Diagnostic Recent Developments/Updates
7.2.6 Bracco Diagnostic Competitive Strengths & Weaknesses
7.3 Guerbet
7.3.1 Guerbet Details
7.3.2 Guerbet Major Business
7.3.3 Guerbet Nuclear Medicine Imaging Agents Product and Services
7.3.4 Guerbet Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Guerbet Recent Developments/Updates
7.3.6 Guerbet Competitive Strengths & Weaknesses
7.4 Mallinckrodt
7.4.1 Mallinckrodt Details
7.4.2 Mallinckrodt Major Business
7.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Product and Services
7.4.4 Mallinckrodt Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Mallinckrodt Recent Developments/Updates
7.4.6 Mallinckrodt Competitive Strengths & Weaknesses
7.5 Lantheus
7.5.1 Lantheus Details
7.5.2 Lantheus Major Business
7.5.3 Lantheus Nuclear Medicine Imaging Agents Product and Services
7.5.4 Lantheus Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lantheus Recent Developments/Updates
7.5.6 Lantheus Competitive Strengths & Weaknesses
7.6 Yantai Dongcheng
7.6.1 Yantai Dongcheng Details
7.6.2 Yantai Dongcheng Major Business
7.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Product and Services
7.6.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Yantai Dongcheng Recent Developments/Updates
7.6.6 Yantai Dongcheng Competitive Strengths & Weaknesses
7.7 Foshan Rui Diao Pharmaceutical
7.7.1 Foshan Rui Diao Pharmaceutical Details
7.7.2 Foshan Rui Diao Pharmaceutical Major Business
7.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product and Services
7.7.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Foshan Rui Diao Pharmaceutical Recent Developments/Updates
7.7.6 Foshan Rui Diao Pharmaceutical Competitive Strengths & Weaknesses
7.8 Cardinal Health
7.8.1 Cardinal Health Details
7.8.2 Cardinal Health Major Business
7.8.3 Cardinal Health Nuclear Medicine Imaging Agents Product and Services
7.8.4 Cardinal Health Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Cardinal Health Recent Developments/Updates
7.8.6 Cardinal Health Competitive Strengths & Weaknesses
7.9 Blue Earth Diagnostics
7.9.1 Blue Earth Diagnostics Details
7.9.2 Blue Earth Diagnostics Major Business
7.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product and Services
7.9.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Blue Earth Diagnostics Recent Developments/Updates
7.9.6 Blue Earth Diagnostics Competitive Strengths & Weaknesses
7.10 Bayer AG
7.10.1 Bayer AG Details
7.10.2 Bayer AG Major Business
7.10.3 Bayer AG Nuclear Medicine Imaging Agents Product and Services
7.10.4 Bayer AG Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bayer AG Recent Developments/Updates
7.10.6 Bayer AG Competitive Strengths & Weaknesses
7.11 Abx Advanced Biochemical
7.11.1 Abx Advanced Biochemical Details
7.11.2 Abx Advanced Biochemical Major Business
7.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product and Services
7.11.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Abx Advanced Biochemical Recent Developments/Updates
7.11.6 Abx Advanced Biochemical Competitive Strengths & Weaknesses
7.12 Eli Lilly and Company
7.12.1 Eli Lilly and Company Details
7.12.2 Eli Lilly and Company Major Business
7.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Product and Services
7.12.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Eli Lilly and Company Recent Developments/Updates
7.12.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.13 Jubilant Pharma Limited
7.13.1 Jubilant Pharma Limited Details
7.13.2 Jubilant Pharma Limited Major Business
7.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product and Services
7.13.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Jubilant Pharma Limited Recent Developments/Updates
7.13.6 Jubilant Pharma Limited Competitive Strengths & Weaknesses
7.14 Navidea
7.14.1 Navidea Details
7.14.2 Navidea Major Business
7.14.3 Navidea Nuclear Medicine Imaging Agents Product and Services
7.14.4 Navidea Nuclear Medicine Imaging Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Navidea Recent Developments/Updates
7.14.6 Navidea Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nuclear Medicine Imaging Agents Industry Chain
8.2 Nuclear Medicine Imaging Agents Upstream Analysis
8.2.1 Nuclear Medicine Imaging Agents Core Raw Materials
8.2.2 Main Manufacturers of Nuclear Medicine Imaging Agents Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nuclear Medicine Imaging Agents Production Mode
8.6 Nuclear Medicine Imaging Agents Procurement Model
8.7 Nuclear Medicine Imaging Agents Industry Sales Model and Sales Channels
8.7.1 Nuclear Medicine Imaging Agents Sales Model
8.7.2 Nuclear Medicine Imaging Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Nuclear Medicine Imaging Agents Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nuclear Medicine Imaging Agents Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nuclear Medicine Imaging Agents Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nuclear Medicine Imaging Agents Production Value Market Share by Region (2018-2023)
Table 5. World Nuclear Medicine Imaging Agents Production Value Market Share by Region (2024-2029)
Table 6. World Nuclear Medicine Imaging Agents Production by Region (2018-2023) & (K Units)
Table 7. World Nuclear Medicine Imaging Agents Production by Region (2024-2029) & (K Units)
Table 8. World Nuclear Medicine Imaging Agents Production Market Share by Region (2018-2023)
Table 9. World Nuclear Medicine Imaging Agents Production Market Share by Region (2024-2029)
Table 10. World Nuclear Medicine Imaging Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nuclear Medicine Imaging Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nuclear Medicine Imaging Agents Major Market Trends
Table 13. World Nuclear Medicine Imaging Agents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nuclear Medicine Imaging Agents Consumption by Region (2018-2023) & (K Units)
Table 15. World Nuclear Medicine Imaging Agents Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nuclear Medicine Imaging Agents Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nuclear Medicine Imaging Agents Producers in 2022
Table 18. World Nuclear Medicine Imaging Agents Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nuclear Medicine Imaging Agents Producers in 2022
Table 20. World Nuclear Medicine Imaging Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nuclear Medicine Imaging Agents Company Evaluation Quadrant
Table 22. World Nuclear Medicine Imaging Agents Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nuclear Medicine Imaging Agents Production Site of Key Manufacturer
Table 24. Nuclear Medicine Imaging Agents Market: Company Product Type Footprint
Table 25. Nuclear Medicine Imaging Agents Market: Company Product Application Footprint
Table 26. Nuclear Medicine Imaging Agents Competitive Factors
Table 27. Nuclear Medicine Imaging Agents New Entrant and Capacity Expansion Plans
Table 28. Nuclear Medicine Imaging Agents Mergers & Acquisitions Activity
Table 29. United States VS China Nuclear Medicine Imaging Agents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nuclear Medicine Imaging Agents Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nuclear Medicine Imaging Agents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nuclear Medicine Imaging Agents Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nuclear Medicine Imaging Agents Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share (2018-2023)
Table 37. China Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nuclear Medicine Imaging Agents Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nuclear Medicine Imaging Agents Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share (2018-2023)
Table 42. Rest of World Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share (2018-2023)
Table 47. World Nuclear Medicine Imaging Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nuclear Medicine Imaging Agents Production by Type (2018-2023) & (K Units)
Table 49. World Nuclear Medicine Imaging Agents Production by Type (2024-2029) & (K Units)
Table 50. World Nuclear Medicine Imaging Agents Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nuclear Medicine Imaging Agents Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nuclear Medicine Imaging Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nuclear Medicine Imaging Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nuclear Medicine Imaging Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nuclear Medicine Imaging Agents Production by Application (2018-2023) & (K Units)
Table 56. World Nuclear Medicine Imaging Agents Production by Application (2024-2029) & (K Units)
Table 57. World Nuclear Medicine Imaging Agents Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nuclear Medicine Imaging Agents Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nuclear Medicine Imaging Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nuclear Medicine Imaging Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 61. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 62. GE HealthCare Major Business
Table 63. GE HealthCare Nuclear Medicine Imaging Agents Product and Services
Table 64. GE HealthCare Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. GE HealthCare Recent Developments/Updates
Table 66. GE HealthCare Competitive Strengths & Weaknesses
Table 67. Bracco Diagnostic Basic Information, Manufacturing Base and Competitors
Table 68. Bracco Diagnostic Major Business
Table 69. Bracco Diagnostic Nuclear Medicine Imaging Agents Product and Services
Table 70. Bracco Diagnostic Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bracco Diagnostic Recent Developments/Updates
Table 72. Bracco Diagnostic Competitive Strengths & Weaknesses
Table 73. Guerbet Basic Information, Manufacturing Base and Competitors
Table 74. Guerbet Major Business
Table 75. Guerbet Nuclear Medicine Imaging Agents Product and Services
Table 76. Guerbet Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Guerbet Recent Developments/Updates
Table 78. Guerbet Competitive Strengths & Weaknesses
Table 79. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 80. Mallinckrodt Major Business
Table 81. Mallinckrodt Nuclear Medicine Imaging Agents Product and Services
Table 82. Mallinckrodt Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Mallinckrodt Recent Developments/Updates
Table 84. Mallinckrodt Competitive Strengths & Weaknesses
Table 85. Lantheus Basic Information, Manufacturing Base and Competitors
Table 86. Lantheus Major Business
Table 87. Lantheus Nuclear Medicine Imaging Agents Product and Services
Table 88. Lantheus Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lantheus Recent Developments/Updates
Table 90. Lantheus Competitive Strengths & Weaknesses
Table 91. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
Table 92. Yantai Dongcheng Major Business
Table 93. Yantai Dongcheng Nuclear Medicine Imaging Agents Product and Services
Table 94. Yantai Dongcheng Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Yantai Dongcheng Recent Developments/Updates
Table 96. Yantai Dongcheng Competitive Strengths & Weaknesses
Table 97. Foshan Rui Diao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Foshan Rui Diao Pharmaceutical Major Business
Table 99. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product and Services
Table 100. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Foshan Rui Diao Pharmaceutical Recent Developments/Updates
Table 102. Foshan Rui Diao Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 104. Cardinal Health Major Business
Table 105. Cardinal Health Nuclear Medicine Imaging Agents Product and Services
Table 106. Cardinal Health Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Cardinal Health Recent Developments/Updates
Table 108. Cardinal Health Competitive Strengths & Weaknesses
Table 109. Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors
Table 110. Blue Earth Diagnostics Major Business
Table 111. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product and Services
Table 112. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Blue Earth Diagnostics Recent Developments/Updates
Table 114. Blue Earth Diagnostics Competitive Strengths & Weaknesses
Table 115. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 116. Bayer AG Major Business
Table 117. Bayer AG Nuclear Medicine Imaging Agents Product and Services
Table 118. Bayer AG Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bayer AG Recent Developments/Updates
Table 120. Bayer AG Competitive Strengths & Weaknesses
Table 121. Abx Advanced Biochemical Basic Information, Manufacturing Base and Competitors
Table 122. Abx Advanced Biochemical Major Business
Table 123. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product and Services
Table 124. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Abx Advanced Biochemical Recent Developments/Updates
Table 126. Abx Advanced Biochemical Competitive Strengths & Weaknesses
Table 127. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 128. Eli Lilly and Company Major Business
Table 129. Eli Lilly and Company Nuclear Medicine Imaging Agents Product and Services
Table 130. Eli Lilly and Company Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Eli Lilly and Company Recent Developments/Updates
Table 132. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 133. Jubilant Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 134. Jubilant Pharma Limited Major Business
Table 135. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product and Services
Table 136. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Jubilant Pharma Limited Recent Developments/Updates
Table 138. Navidea Basic Information, Manufacturing Base and Competitors
Table 139. Navidea Major Business
Table 140. Navidea Nuclear Medicine Imaging Agents Product and Services
Table 141. Navidea Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Nuclear Medicine Imaging Agents Upstream (Raw Materials)
Table 143. Nuclear Medicine Imaging Agents Typical Customers
Table 144. Nuclear Medicine Imaging Agents Typical Distributors
Table 1. World Nuclear Medicine Imaging Agents Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nuclear Medicine Imaging Agents Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nuclear Medicine Imaging Agents Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nuclear Medicine Imaging Agents Production Value Market Share by Region (2018-2023)
Table 5. World Nuclear Medicine Imaging Agents Production Value Market Share by Region (2024-2029)
Table 6. World Nuclear Medicine Imaging Agents Production by Region (2018-2023) & (K Units)
Table 7. World Nuclear Medicine Imaging Agents Production by Region (2024-2029) & (K Units)
Table 8. World Nuclear Medicine Imaging Agents Production Market Share by Region (2018-2023)
Table 9. World Nuclear Medicine Imaging Agents Production Market Share by Region (2024-2029)
Table 10. World Nuclear Medicine Imaging Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nuclear Medicine Imaging Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nuclear Medicine Imaging Agents Major Market Trends
Table 13. World Nuclear Medicine Imaging Agents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nuclear Medicine Imaging Agents Consumption by Region (2018-2023) & (K Units)
Table 15. World Nuclear Medicine Imaging Agents Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nuclear Medicine Imaging Agents Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nuclear Medicine Imaging Agents Producers in 2022
Table 18. World Nuclear Medicine Imaging Agents Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nuclear Medicine Imaging Agents Producers in 2022
Table 20. World Nuclear Medicine Imaging Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nuclear Medicine Imaging Agents Company Evaluation Quadrant
Table 22. World Nuclear Medicine Imaging Agents Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nuclear Medicine Imaging Agents Production Site of Key Manufacturer
Table 24. Nuclear Medicine Imaging Agents Market: Company Product Type Footprint
Table 25. Nuclear Medicine Imaging Agents Market: Company Product Application Footprint
Table 26. Nuclear Medicine Imaging Agents Competitive Factors
Table 27. Nuclear Medicine Imaging Agents New Entrant and Capacity Expansion Plans
Table 28. Nuclear Medicine Imaging Agents Mergers & Acquisitions Activity
Table 29. United States VS China Nuclear Medicine Imaging Agents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nuclear Medicine Imaging Agents Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nuclear Medicine Imaging Agents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nuclear Medicine Imaging Agents Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nuclear Medicine Imaging Agents Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share (2018-2023)
Table 37. China Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nuclear Medicine Imaging Agents Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nuclear Medicine Imaging Agents Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share (2018-2023)
Table 42. Rest of World Based Nuclear Medicine Imaging Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share (2018-2023)
Table 47. World Nuclear Medicine Imaging Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nuclear Medicine Imaging Agents Production by Type (2018-2023) & (K Units)
Table 49. World Nuclear Medicine Imaging Agents Production by Type (2024-2029) & (K Units)
Table 50. World Nuclear Medicine Imaging Agents Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nuclear Medicine Imaging Agents Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nuclear Medicine Imaging Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nuclear Medicine Imaging Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nuclear Medicine Imaging Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nuclear Medicine Imaging Agents Production by Application (2018-2023) & (K Units)
Table 56. World Nuclear Medicine Imaging Agents Production by Application (2024-2029) & (K Units)
Table 57. World Nuclear Medicine Imaging Agents Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nuclear Medicine Imaging Agents Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nuclear Medicine Imaging Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nuclear Medicine Imaging Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 61. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 62. GE HealthCare Major Business
Table 63. GE HealthCare Nuclear Medicine Imaging Agents Product and Services
Table 64. GE HealthCare Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. GE HealthCare Recent Developments/Updates
Table 66. GE HealthCare Competitive Strengths & Weaknesses
Table 67. Bracco Diagnostic Basic Information, Manufacturing Base and Competitors
Table 68. Bracco Diagnostic Major Business
Table 69. Bracco Diagnostic Nuclear Medicine Imaging Agents Product and Services
Table 70. Bracco Diagnostic Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bracco Diagnostic Recent Developments/Updates
Table 72. Bracco Diagnostic Competitive Strengths & Weaknesses
Table 73. Guerbet Basic Information, Manufacturing Base and Competitors
Table 74. Guerbet Major Business
Table 75. Guerbet Nuclear Medicine Imaging Agents Product and Services
Table 76. Guerbet Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Guerbet Recent Developments/Updates
Table 78. Guerbet Competitive Strengths & Weaknesses
Table 79. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 80. Mallinckrodt Major Business
Table 81. Mallinckrodt Nuclear Medicine Imaging Agents Product and Services
Table 82. Mallinckrodt Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Mallinckrodt Recent Developments/Updates
Table 84. Mallinckrodt Competitive Strengths & Weaknesses
Table 85. Lantheus Basic Information, Manufacturing Base and Competitors
Table 86. Lantheus Major Business
Table 87. Lantheus Nuclear Medicine Imaging Agents Product and Services
Table 88. Lantheus Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lantheus Recent Developments/Updates
Table 90. Lantheus Competitive Strengths & Weaknesses
Table 91. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
Table 92. Yantai Dongcheng Major Business
Table 93. Yantai Dongcheng Nuclear Medicine Imaging Agents Product and Services
Table 94. Yantai Dongcheng Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Yantai Dongcheng Recent Developments/Updates
Table 96. Yantai Dongcheng Competitive Strengths & Weaknesses
Table 97. Foshan Rui Diao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Foshan Rui Diao Pharmaceutical Major Business
Table 99. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product and Services
Table 100. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Foshan Rui Diao Pharmaceutical Recent Developments/Updates
Table 102. Foshan Rui Diao Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 104. Cardinal Health Major Business
Table 105. Cardinal Health Nuclear Medicine Imaging Agents Product and Services
Table 106. Cardinal Health Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Cardinal Health Recent Developments/Updates
Table 108. Cardinal Health Competitive Strengths & Weaknesses
Table 109. Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors
Table 110. Blue Earth Diagnostics Major Business
Table 111. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product and Services
Table 112. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Blue Earth Diagnostics Recent Developments/Updates
Table 114. Blue Earth Diagnostics Competitive Strengths & Weaknesses
Table 115. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 116. Bayer AG Major Business
Table 117. Bayer AG Nuclear Medicine Imaging Agents Product and Services
Table 118. Bayer AG Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bayer AG Recent Developments/Updates
Table 120. Bayer AG Competitive Strengths & Weaknesses
Table 121. Abx Advanced Biochemical Basic Information, Manufacturing Base and Competitors
Table 122. Abx Advanced Biochemical Major Business
Table 123. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product and Services
Table 124. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Abx Advanced Biochemical Recent Developments/Updates
Table 126. Abx Advanced Biochemical Competitive Strengths & Weaknesses
Table 127. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 128. Eli Lilly and Company Major Business
Table 129. Eli Lilly and Company Nuclear Medicine Imaging Agents Product and Services
Table 130. Eli Lilly and Company Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Eli Lilly and Company Recent Developments/Updates
Table 132. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 133. Jubilant Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 134. Jubilant Pharma Limited Major Business
Table 135. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product and Services
Table 136. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Jubilant Pharma Limited Recent Developments/Updates
Table 138. Navidea Basic Information, Manufacturing Base and Competitors
Table 139. Navidea Major Business
Table 140. Navidea Nuclear Medicine Imaging Agents Product and Services
Table 141. Navidea Nuclear Medicine Imaging Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Nuclear Medicine Imaging Agents Upstream (Raw Materials)
Table 143. Nuclear Medicine Imaging Agents Typical Customers
Table 144. Nuclear Medicine Imaging Agents Typical Distributors
LIST OF FIGURES
Figure 1. Nuclear Medicine Imaging Agents Picture
Figure 2. World Nuclear Medicine Imaging Agents Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nuclear Medicine Imaging Agents Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 5. World Nuclear Medicine Imaging Agents Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nuclear Medicine Imaging Agents Production Value Market Share by Region (2018-2029)
Figure 7. World Nuclear Medicine Imaging Agents Production Market Share by Region (2018-2029)
Figure 8. North America Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 9. Europe Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 10. China Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 11. Japan Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 12. Nuclear Medicine Imaging Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 15. World Nuclear Medicine Imaging Agents Consumption Market Share by Region (2018-2029)
Figure 16. United States Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 17. China Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 18. Europe Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 19. Japan Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 22. India Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nuclear Medicine Imaging Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nuclear Medicine Imaging Agents Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nuclear Medicine Imaging Agents Markets in 2022
Figure 26. United States VS China: Nuclear Medicine Imaging Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nuclear Medicine Imaging Agents Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nuclear Medicine Imaging Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share 2022
Figure 30. China Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share 2022
Figure 32. World Nuclear Medicine Imaging Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nuclear Medicine Imaging Agents Production Value Market Share by Type in 2022
Figure 34. Fluorine 18 Labeling
Figure 35. Carbon 11 Labeling
Figure 36. Nitrogen 13 Labeling
Figure 37. Oxygen 15 Labeling
Figure 38. Technetium 99 Labeling
Figure 39. Others
Figure 40. World Nuclear Medicine Imaging Agents Production Market Share by Type (2018-2029)
Figure 41. World Nuclear Medicine Imaging Agents Production Value Market Share by Type (2018-2029)
Figure 42. World Nuclear Medicine Imaging Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Nuclear Medicine Imaging Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World Nuclear Medicine Imaging Agents Production Value Market Share by Application in 2022
Figure 45. Early Diagnosis
Figure 46. Clinical Stage
Figure 47. Treatment Evaluation
Figure 48. World Nuclear Medicine Imaging Agents Production Market Share by Application (2018-2029)
Figure 49. World Nuclear Medicine Imaging Agents Production Value Market Share by Application (2018-2029)
Figure 50. World Nuclear Medicine Imaging Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Nuclear Medicine Imaging Agents Industry Chain
Figure 52. Nuclear Medicine Imaging Agents Procurement Model
Figure 53. Nuclear Medicine Imaging Agents Sales Model
Figure 54. Nuclear Medicine Imaging Agents Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Nuclear Medicine Imaging Agents Picture
Figure 2. World Nuclear Medicine Imaging Agents Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nuclear Medicine Imaging Agents Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 5. World Nuclear Medicine Imaging Agents Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nuclear Medicine Imaging Agents Production Value Market Share by Region (2018-2029)
Figure 7. World Nuclear Medicine Imaging Agents Production Market Share by Region (2018-2029)
Figure 8. North America Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 9. Europe Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 10. China Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 11. Japan Nuclear Medicine Imaging Agents Production (2018-2029) & (K Units)
Figure 12. Nuclear Medicine Imaging Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 15. World Nuclear Medicine Imaging Agents Consumption Market Share by Region (2018-2029)
Figure 16. United States Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 17. China Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 18. Europe Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 19. Japan Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 22. India Nuclear Medicine Imaging Agents Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nuclear Medicine Imaging Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nuclear Medicine Imaging Agents Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nuclear Medicine Imaging Agents Markets in 2022
Figure 26. United States VS China: Nuclear Medicine Imaging Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nuclear Medicine Imaging Agents Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nuclear Medicine Imaging Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share 2022
Figure 30. China Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nuclear Medicine Imaging Agents Production Market Share 2022
Figure 32. World Nuclear Medicine Imaging Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nuclear Medicine Imaging Agents Production Value Market Share by Type in 2022
Figure 34. Fluorine 18 Labeling
Figure 35. Carbon 11 Labeling
Figure 36. Nitrogen 13 Labeling
Figure 37. Oxygen 15 Labeling
Figure 38. Technetium 99 Labeling
Figure 39. Others
Figure 40. World Nuclear Medicine Imaging Agents Production Market Share by Type (2018-2029)
Figure 41. World Nuclear Medicine Imaging Agents Production Value Market Share by Type (2018-2029)
Figure 42. World Nuclear Medicine Imaging Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Nuclear Medicine Imaging Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World Nuclear Medicine Imaging Agents Production Value Market Share by Application in 2022
Figure 45. Early Diagnosis
Figure 46. Clinical Stage
Figure 47. Treatment Evaluation
Figure 48. World Nuclear Medicine Imaging Agents Production Market Share by Application (2018-2029)
Figure 49. World Nuclear Medicine Imaging Agents Production Value Market Share by Application (2018-2029)
Figure 50. World Nuclear Medicine Imaging Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 51. Nuclear Medicine Imaging Agents Industry Chain
Figure 52. Nuclear Medicine Imaging Agents Procurement Model
Figure 53. Nuclear Medicine Imaging Agents Sales Model
Figure 54. Nuclear Medicine Imaging Agents Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
